SCHEMBL27693228

SCHEMBL27693228

O=COC1(NC(=O)c2ccc3ccccc3c2OCc2ccc(Cl)cc2)CCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 4/20 0.46
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
KMT2A Q03164 4/20 0.41
RAB9A P51151 3/20 0.41
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
NPC1 O15118 2/20 0.41
XBP1 P17861 1/20 0.41
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
NPBWR1 P48145 1/20 0.39
MCHR1 Q99705 1/20 0.39
MAPT P10636 4/20 0.38
TDP1 Q9NUW8 1/20 0.38
EGLN1 Q9GZT9 1/20 0.38
DRD4 P21917 1/20 0.38
PTPN1 P18031 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27693261 0.92 CXCR2 (0.51) CXCR2PRMT5WDR77KMT2ARAB9A
SCHEMBL27712958 0.90 CXCR2 (0.57) CXCR2KMT2ARAB9AALDH1A1MEN1
SCHEMBL27693224 0.90 CXCR2 (0.45) CXCR2KMT2ARAB9AALDH1A1MEN1
SCHEMBL27713046 0.88 CXCR2 (0.57) CXCR2ALDH1A1NPSR1GAAMAPT
SCHEMBL27693429 0.86 CXCR2 (0.49) CXCR2NPC1MAPT
SCHEMBL27693236 0.85 CXCR2 (0.53) CXCR2RAB9AALDH1A1NPC1KDM4E
SCHEMBL27693220 0.85 CXCR2 (0.46) CXCR2KMT2ARAB9AMEN1
SCHEMBL485602 0.85 CXCR2 (0.63) CXCR2PRMT5WDR77KMT2ARAB9A
SCHEMBL28770785 0.83 CXCR2 (0.42) CXCR2ALDH1A1KDM4EGAAMAPT
SCHEMBL27693207 0.82 ALOX5AP (0.47) CXCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 CN claimed
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 CN disclosed